• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.

作者信息

Zaehner T, Plueshke V, Frey B M, Frey F J, Ferrari P

机构信息

Division of Nephrology and Hypertension, Inselspital, University of Berne, Berne, Switzerland.

出版信息

Kidney Int. 2000 Oct;58(4):1413-9. doi: 10.1046/j.1523-1755.2000.00303.x.

DOI:10.1046/j.1523-1755.2000.00303.x
PMID:11012876
Abstract

BACKGROUND

Mutations in the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) gene cause a rare form of low-renin hypertension leading to end-stage renal disease (ESRD) in some affected subjects. To date, no search for mutations in the HSD11B2 gene was performed in a large population to obtain an estimate its prevalence.

METHODS

The HSD11B2 gene was analyzed in 587 subjects, including 260 ESRD patients (either dialysis or transplanted) for mutations in the exons 2 through 5 and corresponding intronic regions by polymerase chain reaction (PCR) using appropriate overlapping primers, gel analysis by single strand conformational polymorphism (SSCP), and sequencing of identified migration variants.

RESULTS

The prevalence of single-nucleotide polymorphisms (SNPs) in ESRD patients and controls was 26%. The following genetic variants were found among all subjects investigated: exon 2 T442G (Leu148/Val, N = 70) and C470A (Thr156/Thr, N = 67), exon 3 G534A (Glu178/Glu, N = 69), and exon 5 C1274T (Asp388/Asp, N = 2). Four SNPs were identified in intron 4 only. In the control population, the prevalence of the variants Leu148 and Thr156 was 14% each. Glu178 was 11%, while no variants were found in exon 5. In ESRD patients, the prevalence of the variant Leu148 was 9%, and Thr156 was 8%. Glu178 was 13%, while the Asp388 variant was 0.7%. In patients with a short duration between the time of diagnosis of the renal disease and the onset of ESRD, the prevalence of the Leu148 and Glu178 variants was higher than in subjects with slowly progressing renal disease. The 11betaHSD2 activity of all of these SNPs is predictably unaltered.

CONCLUSIONS

There is a high prevalence of SNPs of the HSD11B2 gene, without causing exonic mutations generating a 11betaHSD2 enzyme with altered activity. Based on statistical analyses, the frequency of homozygosity for mutated alleles of the HSD11B2 gene can be derived as <1/250,000 when a Caucasian population is considered.

摘要

相似文献

1
Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.
Kidney Int. 2000 Oct;58(4):1413-9. doi: 10.1046/j.1523-1755.2000.00303.x.
2
Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension.人原发性高血压中2型11β-羟基类固醇脱氢酶基因(HSD11B2)的分析
Am J Hypertens. 2005 Aug;18(8):1091-8. doi: 10.1016/j.amjhyper.2005.02.020.
3
Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients.高血压和肾病患者中血清和糖皮质激素调节激酶(SGK1)基因非保守突变的低发生率。
Nephrol Dial Transplant. 2004 Oct;19(10):2499-504. doi: 10.1093/ndt/gfh417. Epub 2004 Aug 10.
4
A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene.人2型11β-羟类固醇脱氢酶基因中的一个新的多态性限制性酶切位点。
J Clin Endocrinol Metab. 1998 May;83(5):1814-7. doi: 10.1210/jcem.83.5.4933.
5
Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension.
J Hypertens. 1998 Nov;16(11):1627-33. doi: 10.1097/00004872-199816110-00009.
6
11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort.11β-羟类固醇脱氢酶 2 多态性及其在智利原发性高血压和正常血压队列中的活性。
Am J Hypertens. 2012 May;25(5):597-603. doi: 10.1038/ajh.2011.263. Epub 2012 Jan 26.
7
Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy.
Eur J Endocrinol. 2002 Apr;146(4):553-8. doi: 10.1530/eje.0.1460553.
8
A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.与盐皮质激素性高血压相关的2型11β-羟类固醇脱氢酶辅因子结合结构域的突变。
J Clin Endocrinol Metab. 2001 Mar;86(3):1247-52. doi: 10.1210/jcem.86.3.7334.
9
Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.2型11β-羟基类固醇脱氢酶在血压调节中的作用。
Kidney Int. 2000 Apr;57(4):1374-81. doi: 10.1046/j.1523-1755.2000.00978.x.
10
Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.人类盐敏感性的分子基础:2型11β-羟基类固醇脱氢酶的作用
J Clin Endocrinol Metab. 1999 Oct;84(10):3745-9. doi: 10.1210/jcem.84.10.6098.

引用本文的文献

1
Cortisol excess in chronic kidney disease - A review of changes and impact on mortality.慢性肾脏病中的皮质醇过多——变化及其对死亡率影响的综述。
Front Endocrinol (Lausanne). 2023 Jan 17;13:1075809. doi: 10.3389/fendo.2022.1075809. eCollection 2022.
2
The outdoor air pollution and brain health workshop.室外空气污染与大脑健康工作坊。
Neurotoxicology. 2012 Oct;33(5):972-84. doi: 10.1016/j.neuro.2012.08.014. Epub 2012 Sep 5.
3
Perinatal stress and early life programming of lung structure and function.围产期应激与肺结构和功能的早期生命编程。
Biol Psychol. 2010 Apr;84(1):46-56. doi: 10.1016/j.biopsycho.2010.01.007. Epub 2010 Jan 18.
4
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression.11β-羟基类固醇脱氢酶2型表达的表观遗传调控
J Clin Invest. 2004 Oct;114(8):1146-57. doi: 10.1172/JCI21647.
5
Genetics of the mineralocorticoid system in primary hypertension.原发性高血压中盐皮质激素系统的遗传学
Curr Hypertens Rep. 2002 Feb;4(1):18-24. doi: 10.1007/s11906-002-0048-8.